Discovering Novel Biomarkers Through Explainable AI
We identify biological signatures that improve early detection, risk prediction, and clinical decision-making — turning complex data into scalable, low-cost diagnostics.
Explore Our PlatformWho We Are
Biomarker Discovery & Diagnostic Innovation
OmniBio Networks is a biomarker discovery and diagnostic innovation company. We identify novel biological signatures that improve early detection, risk prediction, and clinical decision-making across major diseases.
Our platform integrates metagenomics, antigen discovery, computational biology, and machine learning to generate scalable, low-cost diagnostics that work at the point of care.
As a women-led enterprise based in Chennai with strong clinical partnerships, we're building a multi-product biomarker engine capable of supporting diagnostic development across disease categories.
The Challenges We Address
Complex diseases lack reliable early-detection biomarkers
Traditional methods are slow, expensive, and opaque
Clinicians need diagnostics they can trust and understand
From Biological Data to Clinical Diagnostics
Our proprietary platform integrates four core capabilities to discover, validate, and translate biomarkers into affordable point-of-care diagnostics.
Metagenomics
Comprehensive microbial profiling to uncover novel biological signatures from complex biological samples.
Antigen Discovery
Systematic identification of disease-specific antigens for targeted diagnostic development.
Computational Biology
Advanced bioinformatics pipelines to process, analyze, and interpret high-dimensional biological data.
Machine Learning
Explainable AI models that identify which biomarkers matter and why — building clinical trust and supporting regulatory pathways.
Discovery to Diagnostics
A systematic approach that transforms biological insights into validated clinical tools
Metagenomics and antigen discovery to identify novel biological signatures
Computational biology and ML to validate biomarkers and build predictive models
Validated biomarkers become scalable, low-cost point-of-care diagnostics
What We're Building
Our biomarker engine supports diagnostic development across major disease categories.
Chronic Disease Complications
Microbiome-based diagnostics for diabetic foot ulcer risk stratification.
Infectious Diseases
Early-detection biomarkers for infectious disease management.
Inflammatory Disorders
Novel biological signatures for inflammatory condition monitoring.
Microbiome-Associated Conditions
Diagnostic tools for conditions linked to microbiome dysbiosis.
Partner With Us
Interested in our technology for clinical partnerships, investment opportunities, or collaboration?
Email Us
no-reply@omnibio.io
Location
Chennai, India